Crohn Disease, Ulcerative Colitis
Conditions
Brief summary
The main objective of this project is to assess the occupational insertion of these adult patients with pediatric-onset IBD and to compare it with the general population. The secondary objectives are: 1. to assess the level of education and compare it to that of the general population 2. to assess occupational insertion and the educational level according to: * The disease (Crohn's disease, ulcerative colitis or unclassified colitis) * sex * Age at diagnosis (\<or ≥ 10 years) * The occurence of surgery, the location of the disease, the treatments undertaken * Quality of life 3. Evaluate the patient's feelings about the impact of his illness on occupational insertion and the educational level 4. To describe the quality of life of patients in relation to disease activity and health states (QALY calculation) 5. To assess the responsivness to change of the functional handicap score IBD-DI (n = 200 patients)
Detailed description
Chronic inflammatory bowel diseases (IBD) are responsible for high morbidity and impaired quality of life of patients throughout disease course. Numerous studies have shown the impact of the disease on the quality of life of patients with IBD. However, very little data is available on the level of education and professional integration of patients who started their IBD in childhood. The hypothesis behind the study project is that the level of education and consequently the professional integration of patients with early pediatric IBD: 1) could be different from those of the general population; 2) and that these differences could be influenced by the nature of IBD, the age of its onset and its main characteristics. The main objective of this project is to assess the professional integration of these adult patients with pediatric-onset IBD and to compare it with the general population.
Interventions
None listed
Sponsors
University Hospital, Lille
Ministry of Health, France
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female, aged 25 and over at the time of the study * Subject listed in the EPIMAD registry suffering from certain or probable Crohn's disease, or certain or probable ulcerative colitis, or certain or probable ulcerated proctitis, unclassified colitis, diagnosed between 01/01 / 1988 and 12/31/2011, with an age at diagnosis of less than 17 years (definition of the pediatric cohort of the EPIMAD Registry) * Patient residing in the area of the EPIMAD registry: Nord, Pas-de-Calais, Somme or Seine-Maritime * Patient not opposed to the research * Patient not having objected to the use of their data for ancillary studies when registering in the EPIMAD register
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of active workers in employment | through study completion, an average of 18 months | Rate of active workers in employment collected using a standardized self-questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Educational level | through study completion, an average of 18 months | Description of educational level collected using a standardized self-administered questionnaire |
| Association between occupational insertion and disease variables | through study completion, an average of 18 months | Associated factors are : disease type (Crohn / Ulcerative colitis), gender, location of the disease at diagnosis, surgery, treatments, age at diagnosis |
| Association between occupational insertion and quality of life | through study completion, an average of 18 months | Quality of life as measured by SIBDQ questionnaire. |
| Association between educational level and disease variables | through study completion, an average of 18 months | Associated factors are : disease type (Crohn / Ulcerative colitis), gender, location of the disease at diagnosis, surgery, treatments, age at diagnosis |
| Association between educational level and quality of life | through study completion, an average of 18 months | Quality of life as measured by SIBDQ questionnaire. |
| Percentage of patients for whom the disease had an influence on the choice of studies | through study completion, an average of 18 months | This question is directly asked to the patient and reflects its own feeling |
| Percentage of patients for whom the disease had an influence on the course of the studies | through study completion, an average of 18 months | This question is directly asked to the patient and reflects its own feeling |
| Percentage of patients for whom the disease had an influence on the choice of profession | through study completion, an average of 18 months | This question is directly asked to the patient and reflects its own feeling |
| Quality of life as measured by EQ5D-5L questionnaire | through study completion, an average of 18 months | Quality of life as measured by EQ5D-5L questionnaire and transformed into utility according to French reference values. Quality of life will be described according to age, disease activity and surgery. |
| Disease activity for Crohn's patients | through study completion, an average of 18 months | As measured by HBI (Harvey-Bradshaw Index). Disease activity will be used to describe quality of life according to disease state and to assessed sensitivity to change of IBD-Disability Index. |
| Disease activity for Ulcerative Colitis patients | through study completion, an average of 18 months | As measured by SCCAI questionnaire (Simple Clinical Colitis Activity Index). Disease activity will be used to describe quality of life according to disease state and to assessed sensitivity to change of IBD-Disability Index. |
| Disability in 200 patients | through study completion, an average of 18 months | As measured by IBD-DI (IBD Disability Index) in 200 patients previously questioned in 2012 in order to address the question of sensitivity to change of IBD-DI. Measure of change is disease activity as measured by HBI-Index for Crohn's patients and SCCAI for Ulcerative Colitis patients. |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORDominique Turck, MD,PhD
University Hospital, Lille
Outcome results
None listed